chloramphenicol has been researched along with sulfalene in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
| Babak, VI; Gebesh, VV; Ianushevskaia, RI; Kirienko, MS; Lysak, LI | 1 |
| Akinfova, TA; Andruse, AA; Bliuger, AF; Novitskiĭ, IN; Veksler, KhM | 1 |
1 trial(s) available for chloramphenicol and sulfalene
| Article | Year |
|---|---|
[Kelfizin effectiveness in acute dysentery].
Topics: Acute Disease; Adolescent; Adult; Aged; Chloramphenicol; Clinical Trials as Topic; Delayed-Action Preparations; Drug Evaluation; Dysentery, Bacillary; Furazolidone; Humans; Middle Aged; Sulfalene; Sulfanilamides | 1977 |
2 other study(ies) available for chloramphenicol and sulfalene
| Article | Year |
|---|---|
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
[Comparative efficacy of different methods in treatment of patients with acute dysentery].
Topics: Acute Disease; Adult; Biological Products; Bromelains; Chloramphenicol; Clioquinol; Dehydrocholic Acid; Drug Combinations; Dysentery; Escherichia coli; Female; Furazolidone; Humans; Lactobacillus; Pancreatin; Sulfalene; Uracil | 1977 |